NEW YORK (GenomeWeb) – The GenomeWeb Index of 31 firms operating in the molecular diagnostics and omics tools industries beat the broader stock market in June with four of the firms providing a double-digit increase in their stock prices.

Overall, the GenomeWeb Index climbed 2 percent month over month, compared to 2 percent declines for both the Dow Jones Industrial Average and the Nasdaq, and beating the Nasdaq Biotech Index, which closed up slightly more than 1 percent month over month.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.